Page 4 - Refractive Surgery News Today

Decision ensures continued access to comprehensive outflow procedure enabled by OMNI® Surgical System technology for glaucoma patients...

An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.

A single travoprost implant proved noninferior to timolol eye drops, with good safety

(This story has not been edited by THE WEEK and is auto-generated from a PTI

For those tired of glasses and contact lenses, Sun Laser Vision Center offers the perfect solution.This leading vision correction center, voted as the best in

MELBOURNE, Australia, Oct. 30, 2023 -- Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced...

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, ASX:OPT)), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal

Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The

Dr. Thomas James (T.J.) Avallone, an Ophthalmologist specializing in Glaucoma, Cataract, Anterior-Segment, and Refractive Surgery, will soon join Dr. Bill Bigham as Crown City Eye Center’s newest edition.

Greater Austin Community Overwhelmingly Chooses Dell Laser Consultants ...